Start exploring your own markets for free

🚀 Try for Free

/AI Therapeutics
Invite

Pending to review

Not sure yet

Interested

Not interested

Showing 104 companies

Download list

Company
Fit assessment
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on

Genome Biologics effectively leverages machine learning for drug development, pattern discovery, and the expansion of novel therapeutics, including drug repurposing.

Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.
  • Drug Repurposing
Light Search
Germany20171 - 10$20.20MVenture - Series Unknown, $17.33M, October 6, 2021
Oct 14, 2024

Sonrai Analytics effectively utilizes machine learning to discover new patterns and expand therapeutic options, supporting drug repurposing initiatives.

Sonrai develop applications and interfaces to utilize the data and the resultant outputs of analysis and combine this with AI and ML to make your data predictive.
  • Drug Repurposing
  • Biomarker Identification
Light Search
Belfast (United Kingdom)201811 - 50$3.48MVenture - Series Unknown, November 10, 2022
Oct 14, 2024

Purposeful effectively leverages machine learning and pattern discovery to expand therapeutics through drug repurposing, maximizing the potential of existing drugs.

Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.
  • Drug Repurposing
Light Search
Athens (Greece)20181 - 10$200.00KPre-Seed, $200.00K, October 18, 2018
Oct 14, 2024

Chemotargets leverages machine learning for drug discovery, actively discovers patterns in drug safety, and expands therapeutic applications through drug repositioning.

Chemotargets SL is a computationally-oriented biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals. Located in Barcelona, it was founded on March 2006 as a spin-off initiative from Dr. Mestres'​ Systems Pharmacology lab under the auspices of the Hospital del Mar Medical Research Institute (IMIM).Chemotargets’s goal is to help the pharmaceutical and cosmetics industry fast-forward the process of bringing new products to market, speeding up discovery and development programs and making them more cost-efficient. To this end, Chemotargets has designed, and continues to develop, the integrative CLARITY platform, involving a broad spectrum of cutting-edge computational methodologies and analytics tools.
  • Drug Repurposing
Light Search
Barcelona (Spain)200611 - 50NA
Oct 14, 2024

Galactica Biotech effectively leverages machine learning and advanced analytical methods to discover new therapeutic applications for existing drugs, fulfilling all specified requirements.

Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market, and in development, for major and orphan diseases, reducing the risk for patients as well as time and cost for companies.
  • Drug Discovery Optimization
  • Drug Repurposing
Light Search
Cork (Ireland)20171 - 10Seed, June 7, 2017
Oct 14, 2024

GATC Health effectively leverages machine learning to discover health patterns and expand therapeutics, while also utilizing its platform for potential drug repurposing.

GATC Health is an AI company transforming drug development and disease prediction. GATC’s Multiomics Advanced Technology™ (MAT) AI replicates complex systems biology using all data types to accurately predict efficacy, safety, and off-target effects. GATC is transforming the future of medicine with significantly increased accuracy, efficiency, and speed.
  • Drug Repurposing
Light Search
Irvine (United States)202011 - 50$5.41MSeed, $240.00K, August 23, 2023
Oct 14, 2024

The company effectively leverages machine learning to enhance drug discovery, identify novel candidates, and discover new patterns in molecular activity.

Optic is a content identification engine for Web3 that keeps an eye on blockchains to show where and how each NFT originated. The company is based in San Francisco, CA.
  • Drug Discovery Optimization
Light Search
San Francisco (United States)200611 - 50$11.00MSeed, $11.00M, July 20, 2022
Oct 14, 2024

BioXcel Corporation effectively utilizes machine learning and AI technologies to expand therapeutics and discover new patterns, while also engaging in drug repurposing initiatives.

Operator of a biopharmaceutical firm intended to improve the clinical and regulatory success of drug development. The company utilizes artificial intelligence and big data analytics to advance the wave of medicines by developing medicines in immuno-oncology, neuroscience and rare diseases with high unmet needs, enabling clients to impact pharma productivity and innovation to benefit the entire healthcare ecosystem.
  • Drug Repurposing
Light Search
Branford (United States)200511 - 50NA
Oct 14, 2024

Formation Bio effectively leverages machine learning and innovative technologies to expand therapeutic options and repurpose existing drugs, enhancing the drug development process.

Formation Bio is a biotechnology company that focuses on drug development to provide new treatments to patients faster by reimagining clinical trials.
  • Drug Repurposing
Light Search
New York (United States)201351 - 200$528.00MSeries D, $372.00M, June 26, 2024
Oct 14, 2024

Recursion leverages machine learning to discover new biological patterns and expand therapeutic options, including drug repurposing.

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
  • Drug Repurposing
With Momentum
Light Search
Salt Lake City (United States)2013501 - 1000$3.78BPost-IPO Equity, $200.00M, June 26, 2024
Oct 14, 2024

Use "Get more companies" to continue searching, or run a “Deep Dive” for a comprehensive mapping